Skip to main content
Not Found
Digital Seminar

GI Pharmacology Update: Prescribing for Patient Outcome Achievement

Peter Buch, MD, AGAF, FACP
2 Hours 30 Minutes
Audio and Video
Jun 30, 2021
Product Code:
Media Type:
Digital Seminar


  • How do we choose the “best treatment” for Eosinophilic Esophagitis? 
  • Why are there so many recurrences of Helicobacter pylori? 
  • What are the best options for treating C. difficile? 

Please join Clinical Gastroenterologist Dr. Peter Buch as he explores the answers to these and many other questions in this advanced, case-based, and evidence-supported training event.  At the end of this session, you will have new knowledge on the best pharmacologic practices for the most common GI concerns seen in practice. 


Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.

* Credit Note - **

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

Nurses - Pharmacology Nurse Practitioners

This self-study program offers instructional minutes of pharmacology content which is designed to qualify for 2.5 contact hours toward your pharmacology requirement. 

Nurses - Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 2.5 contact hours. Expires: 06/30/2024.

Nurses - California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 2.5 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Nurses - Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 2.5 self-study contact hours.

CE Broker

Nurses - Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 2.5 self-study contact hours. Please email with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.

Physicians Assistants - Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 2.5 hours for completing this self-study program. This activity was originally recorded on 06/30/2021. It was last reviewed on 10/17/2021 and is valid until 10/17/2024


PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™.

Other Professions

This self-study activity qualifies for 2.5 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Peter Buch, MD, AGAF, FACP's Profile

Peter Buch, MD, AGAF, FACP Related seminars and products

Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist,  leading a team that treats all GI conditions. Dr. Buch sits on editorial boards for numerous professional journals and is a highly sought-after international presenter.

Dr. Buch has a passion for teaching. His style is case-based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.


Speaker Disclosures:
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.


Content Disclosure:

Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome, and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.



Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Visit our FAQ page at or contact us at


  1. Determine the current best medication practices for inflammatory bowel disease. 
  2. Detect which medical conditions respond to probiotics. 
  3. Analyze the best pharmacological strategies for PPI use. 
  4. Explore important updates in clostridium difficile treatment. 
  5. Plan to incorporate the newest strategies for successful treatment of Irritable Bowel Syndrome.


Eosinophilic Esophagitis 
  • Proton pump inhibitor (PPI) use 
  • Swallowed steroids 
  • Elimination diet 
Helicobacter Pylori 
  • Testing regimens 
  • Clarithromycin resistance and need for quadruple therapy 
  • Pill burden and risk of recurrence 
  • How to manage refractory H pylori 
Proton pump inhibitors (PPIs) 
  • Who needs chronic therapy 
  • REAL side effects of PPIs 
Gastroparesis Diagnosis & Medication Choices 
  • Metoclopramide 
  • Erythromycin 
  • Symptomatic care 
Clostridium Difficile 
  • Should we still be using Metronidazole? 
  • Vancomycin 
  • Fidaxomicin 
  • Fecal transplants - the ultimate probiotic 
  • Bezlotoxumab 
Irritable Bowel Syndrome 
  • Are probiotics effective? 
  • OTC therapies 
  • Glutamine/Peppermint/Iberogast 
  • Antispasmodics 
  • Rifaximin 
  • Eluxadoline 
  • Lubiprostone/Linaclotide/Plecanitide/Prucalopride 
  • Antidepressants  
GI Bleeding    
  • When to use vitamin K and fresh frozen plasma  
  • When to reverse direct oral anticoagulants 
  • The management of GI bleeding and recent stent placement 
Inflammatory Bowel Disease 
  • When to consider 5 ASAs 
  • Antibiotics 
  • Steroids 
  • Antimetabolites 
  • Anti TNFs 
  • Vedolizumab 
  • Ustekinumab 
  • Tofacitiniub 
  • Biosimilars 
Opioid Induced Constipation 
  • How to choose among: Osmotic or stimulant laxatives 
  • PAMORAS: Naloxegol,Naldemedine, Methylnaltrexone 
  • Secretogogues like Lubiprostone 
  • Selective 5HT4 agonist like Prucalopride 
Liver Diseases 
  • Non-selective beta blockers to prevent variceal bleeding 
  • Statin use and the liver 
  • Acetaminophen safety in chronic liver disease 
  • Hepatitis C regimens 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants


Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

Please wait ...

Back to Top